Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      SEEN Hair Care Announces Breakthrough Clinical Findings in Women's Hair Regrowth Science

      SEEN logo (PRNewsfoto/SEEN)

      News provided by

      SEEN

      May 19, 2026, 09:00 ET

      Share this article

      Share this article


      New Study Presented at SCALE's Dermatology Meeting Demonstrates that SEEN's Non-Comedogenic, Non-Irritating Hair Care Regimen Potentiates Minoxidil 5% Foam's Efficacy, Resulting in 1.7X Increase in Non-Vellus Hair Counts, Compared to Minoxidil 5% Foam and Usual Hair Products

      BETHESDA, Md., May 19, 2026 /PRNewswire/ -- SEEN, the dermatologist-founded hair care brand that is redefining and raising the bar on the "skinification" of hair, today announces an E-poster presented at the 2026 Music City Symposium for Cosmetic Advances and Laser Education (SCALE) held from May 14-17, 2026, in Nashville, Tennessee.

      Continue Reading
      SEEN Minoxidil Study Results
      SEEN Minoxidil Study Results

      The E-poster summarizes the groundbreaking clinical study results demonstrating that the SEEN non-comedogenic, non-irritating hair care regimen potentiates the efficacy of minoxidil 5% foam. The study found a 70% increase in non-vellus hair counts in women with mild-to-moderate hair loss using minoxidil 5% foam and SEEN's non-comedogenic, non-irritating Shampoo and Conditioner, versus a control arm using minoxidil 5% foam and their usual hair products. Topical minoxidil is the only FDA-approved topical medication for female pattern hair loss.

      Information on the E-poster is as follows:

      • Title: A Non-Comedogenic, Non-Irritating Hair Care Regimen Potentiates the Efficacy of Topical Minoxidil 5% Foam in Women With Hair Loss
      • Authors: Iris K. Rubin, MD (Founder and Chief Medical Officer, SEEN); Marc R. Avram, MD (Clinical Professor of Dermatology, Weill Cornell Medical College); Tim Houser, MS (CSO, KGL Skin Study Center); and Stuart R. Lessin, MD (Medical Director, KGL Skin Study Center).

      The Science of "Clear Follicles"
      Dr. Rubin hypothesized that because traditional hair care products can be comedogenic (pore-clogging), they may create a barrier that inhibits penetration by topical treatments. By using SEEN's non-comedogenic formulas to keep the hair follicles clear, minoxidil may be better able to penetrate the follicle and perform with significantly greater efficacy. Further, SEEN's hair care regimen also supports scalp and follicle health by removing many common irritants and allergens. SEEN is clinically proven to be safe for sensitive scalp and skin.

      Clinical Study Design
      The presented data stems from a 6-month, randomized, observer-blinded, two-arm clinical study enrolling 46 women (ages 25–70) with mild-to-moderate hair loss.

      • SEEN Combination Arm: Participants used SEEN Shampoo, SEEN Conditioner, and optional SEEN styling products with minoxidil 5% foam.
      • Control Arm: Participants used minoxidil 5% foam and their usual hair products.

      Researchers used advanced phototrichograms to measure hair counts at baseline, 3 months, and 6 months.

      Statistically Significant 6-Month Results

      • 1.7X Increase in Non-Vellus Hair Counts: Women in the SEEN Combination arm achieved 70% more non-vellus hairs counts at 6 months, compared to the Control arm. Non-vellus hair counts refers to the number of thicker, more visible hairs on the scalp, rather than the very fine, soft "peach fuzz" hairs known as vellus hairs.
      • Patient-Reported Outcomes (PRO): Self-assessments revealed substantial improvements in the SEEN Combination arm versus the Control arm at 6 months:
        • 92% reported fuller-looking hair (vs. 73% in Control).
        • 88% reported hair looks healthier (vs. 73% in Control).
        • 83% reported hair feels thicker (vs. 59% in Control).
        • 79% reported the scalp is noticeably less visible (vs. 50% in Control).

      "Hair care that supports scalp and follicle health is essential to optimize hair regrowth results," said Dr. Iris Rubin, Founder and Chief Medical Officer of SEEN. "SEEN supports healthy hair follicles and scalp health by helping keep the hair follicle clear, and removing many common irritants and allergens. The study results highlight the importance of a hair care regimen in supporting treatment outcomes with minoxidil 5% foam for women experiencing hair loss."

      For additional information regarding clinical data or products, visit www.helloseen.com.

      About SEEN 
      SEEN is #1 Dermatologist-Recommended Safe for Sensitive Skin Prestige Hair Care.* SEEN creates award-winning, dermatologist-designed hair care that transforms your hair, scalp, and skin. SEEN is sampled by 10,000+ Dermatologists, Aestheticians, Other Healthcare Providers, and Stylists, and SEEN is available at helloseen.com, Amazon.com, and Ulta Beauty.

      After repeatedly breaking out from hair products and making the connection between hair products and skin health, Harvard-trained dermatologist (with five diplomas from Harvard Medical School) Dr. Iris Rubin designed SEEN's innovative line that is safe for sensitive skin and scalp, and acne-prone skin. SEEN's fragrance-free line has been awarded the National Eczema Association's Seal of Acceptance. SEEN is clean, vegan, cruelty-free, color-safe, and formulated without clogging oils, silicones, phthalates, parabens, dyes, gluten, or formaldehyde-releasing preservatives.

      *Based on IQVIA ProVoice® February 2026 survey of 300 dermatologists regarding their average weekly recommendations of Safe for Sensitive Skin Prestige Hair Care. The survey defined Prestige Hair Care as products having selective distribution, premium pricing, and performance-led positioning supported by professional or clinical authority. This claim does not imply dermatologists recommend SEEN over all hair care products or over products outside the surveyed category.  

      Media Contact:
      [email protected]

      SOURCE SEEN

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.